- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/12 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 498/12
Total number of patents in this class: 80
10-year publication summary
|
2
|
5
|
4
|
5
|
4
|
6
|
11
|
8
|
4
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7808 |
4 |
| Revolution Medicines, Inc. | 336 |
3 |
| Salix Pharmaceuticals, Ltd. | 45 |
3 |
| BlossomHill Therapeutics, Inc. | 47 |
3 |
| Hoffmann-La Roche Inc. | 3818 |
2 |
| The Regents of the University of Michigan | 5016 |
2 |
| Actelion Pharmaceuticals Ltd | 489 |
2 |
| Agenebio, Inc. | 44 |
2 |
| AREVIPHARMA GmbH | 7 |
2 |
| Azad Pharma AG | 22 |
2 |
| Indena S.p.A. | 595 |
2 |
| Katholieke Universiteit Leuven | 1298 |
2 |
| Salix Pharmaceuticals, Inc. | 79 |
2 |
| Tiumbio Co., Ltd. | 22 |
2 |
| S*BIO Pte Ltd. | 20 |
2 |
| Innovstone Therapeutics Limited | 34 |
2 |
| Fochon Biosciences, Ltd. | 25 |
2 |
| Bristol-myers Squibb Company | 4757 |
1 |
| Genentech, Inc. | 4114 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Other owners | 38 |